NO301929B1 - 4-aryl-tiazol- eller -imidazol-derivater - Google Patents
4-aryl-tiazol- eller -imidazol-derivater Download PDFInfo
- Publication number
- NO301929B1 NO301929B1 NO921156A NO921156A NO301929B1 NO 301929 B1 NO301929 B1 NO 301929B1 NO 921156 A NO921156 A NO 921156A NO 921156 A NO921156 A NO 921156A NO 301929 B1 NO301929 B1 NO 301929B1
- Authority
- NO
- Norway
- Prior art keywords
- thiazole
- carboxamide
- phenyl
- hydroxy
- carboximidamide
- Prior art date
Links
- 150000002460 imidazoles Chemical class 0.000 title abstract description 4
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 10
- IQGSYVPGKNJALP-UHFFFAOYSA-N 4-(4-chlorophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=CC(Cl)=CC=2)=C1 IQGSYVPGKNJALP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 8
- 239000001257 hydrogen Substances 0.000 claims abstract description 8
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 6
- 150000002367 halogens Chemical class 0.000 claims abstract description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 6
- 206010019280 Heart failures Diseases 0.000 claims abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
- 208000006673 asthma Diseases 0.000 claims abstract description 5
- 125000001424 substituent group Chemical group 0.000 claims abstract description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 3
- 125000004001 thioalkyl group Chemical group 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 4
- BSTDPPPLYKJYEO-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=C(Cl)C(Cl)=CC=2)=C1 BSTDPPPLYKJYEO-UHFFFAOYSA-N 0.000 claims description 3
- MIXLZCYFMQNQDD-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound C1=C(OC)C(OC)=CC=C1C1=CSC(C(N)=NO)=N1 MIXLZCYFMQNQDD-UHFFFAOYSA-N 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- QCEMLOKIEVVRPZ-UHFFFAOYSA-N 4-(3-chloro-4,5-dimethoxyphenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical group ClC1=C(OC)C(OC)=CC(C=2N=C(SC=2)C(=N)NO)=C1 QCEMLOKIEVVRPZ-UHFFFAOYSA-N 0.000 claims description 2
- FYUWXCNELXARTI-UHFFFAOYSA-N 5-(3,4-dimethylphenyl)-N'-hydroxy-1H-imidazole-2-carboximidamide Chemical compound C1=C(C)C(C)=CC=C1C1=CNC(C(=N)NO)=N1 FYUWXCNELXARTI-UHFFFAOYSA-N 0.000 claims description 2
- KXCQDIWJQBSUJF-UHFFFAOYSA-N 4-phenyl-1,3-thiazole Chemical compound S1C=NC(C=2C=CC=CC=2)=C1 KXCQDIWJQBSUJF-UHFFFAOYSA-N 0.000 claims 1
- XHLKOHSAWQPOFO-UHFFFAOYSA-N 5-phenyl-1h-imidazole Chemical class N1C=NC=C1C1=CC=CC=C1 XHLKOHSAWQPOFO-UHFFFAOYSA-N 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract description 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract description 2
- 229940124630 bronchodilator Drugs 0.000 abstract description 2
- 230000000747 cardiac effect Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 210000003365 myofibril Anatomy 0.000 abstract description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 235000010290 biphenyl Nutrition 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- -1 4-(3-chloro-4,5-dimethoxy-phenyl)-N-hydroxy-thiazole-2-carboxamide Chemical compound 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- AVYBERINYRMRTR-UHFFFAOYSA-N 5-phenyl-1h-imidazole-2-carboxamide Chemical compound N1C(C(=O)N)=NC(C=2C=CC=CC=2)=C1 AVYBERINYRMRTR-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000011181 potassium carbonates Nutrition 0.000 description 4
- XHAYBUXBCCPCRL-UHFFFAOYSA-N 4-(3-chloro-4,5-dimethoxyphenyl)-1,3-thiazole-2-carboxamide Chemical compound ClC1=C(OC)C(OC)=CC(C=2N=C(SC=2)C(N)=O)=C1 XHAYBUXBCCPCRL-UHFFFAOYSA-N 0.000 description 3
- VPCNHYHCNXZJAV-UHFFFAOYSA-N 4-(3-chloro-5-methoxy-4-methylthiophen-2-yl)-1,3-thiazole-2-carboxamide Chemical compound CC1=C(OC)SC(C=2N=C(SC=2)C(N)=O)=C1Cl VPCNHYHCNXZJAV-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- LFCCVJXZLGAFGN-UHFFFAOYSA-N 2-bromo-1-(3-chloro-4,5-dimethoxyphenyl)ethanone Chemical compound COC1=CC(C(=O)CBr)=CC(Cl)=C1OC LFCCVJXZLGAFGN-UHFFFAOYSA-N 0.000 description 2
- ONOOPHIHUQNUNI-UHFFFAOYSA-N 4-(3-chloro-4,5-dimethoxyphenyl)-1,3-thiazole-2-carbonitrile Chemical compound ClC1=C(OC)C(OC)=CC(C=2N=C(SC=2)C#N)=C1 ONOOPHIHUQNUNI-UHFFFAOYSA-N 0.000 description 2
- ISHGTFOPDPGSHQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=CC(Cl)=CC=2)=C1 ISHGTFOPDPGSHQ-UHFFFAOYSA-N 0.000 description 2
- VZYJYKJYUQHDMJ-UHFFFAOYSA-N 4-phenyl-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=CC=CC=2)=C1 VZYJYKJYUQHDMJ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- SSBLFQUOASMILG-UHFFFAOYSA-N ethyl 4-(3-chloro-4,5-dimethoxyphenyl)-1,3-thiazole-2-carboxylate Chemical compound S1C(C(=O)OCC)=NC(C=2C=C(OC)C(OC)=C(Cl)C=2)=C1 SSBLFQUOASMILG-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- RLPMSNUHOBJXND-UHFFFAOYSA-N methyl 4-(3-chloro-5-methoxy-4-methylthiophen-2-yl)-1,3-thiazole-2-carboxylate Chemical compound S1C(C(=O)OC)=NC(C2=C(C(C)=C(OC)S2)Cl)=C1 RLPMSNUHOBJXND-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- LBKPMNBCFAEPBT-UHFFFAOYSA-N 1-(3-chloro-4,5-dimethoxyphenyl)ethanone Chemical compound COC1=CC(C(C)=O)=CC(Cl)=C1OC LBKPMNBCFAEPBT-UHFFFAOYSA-N 0.000 description 1
- GJDSMXZDKYUSGO-UHFFFAOYSA-N 1-methyl-4-(3-methylphenyl)imidazole-2-carboxamide Chemical compound CC1=CC=CC(C=2N=C(N(C)C=2)C(N)=O)=C1 GJDSMXZDKYUSGO-UHFFFAOYSA-N 0.000 description 1
- FUNBQBAQDDQDOR-UHFFFAOYSA-N 4-(2,3-dichlorophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C(=C(Cl)C=CC=2)Cl)=C1 FUNBQBAQDDQDOR-UHFFFAOYSA-N 0.000 description 1
- WJABVSYZDISIKX-UHFFFAOYSA-N 4-(2,3-dichlorophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C(=C(Cl)C=CC=2)Cl)=C1 WJABVSYZDISIKX-UHFFFAOYSA-N 0.000 description 1
- MYQZAGARZRBMGO-UHFFFAOYSA-N 4-(2,5-dichlorophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C(=CC=C(Cl)C=2)Cl)=C1 MYQZAGARZRBMGO-UHFFFAOYSA-N 0.000 description 1
- QEGOMBVNYMYHIX-UHFFFAOYSA-N 4-(2,5-dichlorophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C(=CC=C(Cl)C=2)Cl)=C1 QEGOMBVNYMYHIX-UHFFFAOYSA-N 0.000 description 1
- HMPRQIHNQZXYHC-UHFFFAOYSA-N 4-(2-chloro-3,4-dimethoxyphenyl)-1,3-thiazole-2-carboxamide Chemical compound ClC1=C(OC)C(OC)=CC=C1C1=CSC(C(N)=O)=N1 HMPRQIHNQZXYHC-UHFFFAOYSA-N 0.000 description 1
- KABOGOJZZPBIJE-UHFFFAOYSA-N 4-(2-chlorophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C(=CC=CC=2)Cl)=C1 KABOGOJZZPBIJE-UHFFFAOYSA-N 0.000 description 1
- SXCPZUAMVDMADQ-UHFFFAOYSA-N 4-(2-chlorophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C(=CC=CC=2)Cl)=C1 SXCPZUAMVDMADQ-UHFFFAOYSA-N 0.000 description 1
- GZDXUMORPZQJNC-UHFFFAOYSA-N 4-(2-fluorophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C(=CC=CC=2)F)=C1 GZDXUMORPZQJNC-UHFFFAOYSA-N 0.000 description 1
- OMDUJTZIOBPPMN-UHFFFAOYSA-N 4-(2-fluorophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C(=CC=CC=2)F)=C1 OMDUJTZIOBPPMN-UHFFFAOYSA-N 0.000 description 1
- IRCUSBQJPMUTMV-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=C(Cl)C(Cl)=CC=2)=C1 IRCUSBQJPMUTMV-UHFFFAOYSA-N 0.000 description 1
- KKWWESVWJKAKNI-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-1,3-thiazole-2-carboxamide Chemical compound C1=C(OC)C(OC)=CC=C1C1=CSC(C(N)=O)=N1 KKWWESVWJKAKNI-UHFFFAOYSA-N 0.000 description 1
- KHHVIBQWYXORIY-UHFFFAOYSA-N 4-(3,4-dimethylphenyl)-1,3-thiazole-2-carboxamide Chemical compound C1=C(C)C(C)=CC=C1C1=CSC(C(N)=O)=N1 KHHVIBQWYXORIY-UHFFFAOYSA-N 0.000 description 1
- SMGSGRZQCIXQJY-UHFFFAOYSA-N 4-(3,4-dimethylphenyl)-1-methylimidazole-2-carboxamide Chemical compound C1=C(C)C(C)=CC=C1C1=CN(C)C(C(N)=O)=N1 SMGSGRZQCIXQJY-UHFFFAOYSA-N 0.000 description 1
- VGHLDCHCKNIJHP-UHFFFAOYSA-N 4-(3,4-dimethylphenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound C1=C(C)C(C)=CC=C1C1=CSC(C(=N)NO)=N1 VGHLDCHCKNIJHP-UHFFFAOYSA-N 0.000 description 1
- JHULMCURQXBKDK-UHFFFAOYSA-N 4-(3,4-dimethylphenyl)-N'-hydroxy-1-methylimidazole-2-carboximidamide methanesulfonic acid Chemical compound CS(O)(=O)=O.Cc1ccc(cc1C)-c1cn(C)c(n1)C(=N)NO JHULMCURQXBKDK-UHFFFAOYSA-N 0.000 description 1
- VOGOHEISVIMCPZ-UHFFFAOYSA-N 4-(3,5-dichlorophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=C(Cl)C=C(Cl)C=2)=C1 VOGOHEISVIMCPZ-UHFFFAOYSA-N 0.000 description 1
- KZLRHGOHWVOVMV-UHFFFAOYSA-N 4-(3,5-dichlorophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=C(Cl)C=C(Cl)C=2)=C1 KZLRHGOHWVOVMV-UHFFFAOYSA-N 0.000 description 1
- WINSSLCYJRUUNN-UHFFFAOYSA-N 4-(3-bromophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=C(Br)C=CC=2)=C1 WINSSLCYJRUUNN-UHFFFAOYSA-N 0.000 description 1
- UAIHMOAXNWZDRP-UHFFFAOYSA-N 4-(3-bromophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=C(Br)C=CC=2)=C1 UAIHMOAXNWZDRP-UHFFFAOYSA-N 0.000 description 1
- GPRGWIFPMCQJFT-UHFFFAOYSA-N 4-(3-chloro-4-ethoxy-5-methoxyphenyl)-1,3-thiazole-2-carboxamide Chemical compound C1=C(OC)C(OCC)=C(Cl)C=C1C1=CSC(C(N)=O)=N1 GPRGWIFPMCQJFT-UHFFFAOYSA-N 0.000 description 1
- SURKXFRHSPPOBH-UHFFFAOYSA-N 4-(3-chloro-4-ethoxy-5-methoxyphenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound C1=C(OC)C(OCC)=C(Cl)C=C1C1=CSC(C(=N)NO)=N1 SURKXFRHSPPOBH-UHFFFAOYSA-N 0.000 description 1
- NZGCBIOUVRMJBY-UHFFFAOYSA-N 4-(3-chloro-4-hydroxy-5-methoxyphenyl)-1,3-thiazole-2-carboxamide Chemical compound ClC1=C(O)C(OC)=CC(C=2N=C(SC=2)C(N)=O)=C1 NZGCBIOUVRMJBY-UHFFFAOYSA-N 0.000 description 1
- PHWBLRCYHKITRY-UHFFFAOYSA-N 4-(3-chloro-5-methoxy-4-methylthiophen-2-yl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound ClC1=C(SC(=C1C)OC)C=1N=C(SC1)C(NO)=N PHWBLRCYHKITRY-UHFFFAOYSA-N 0.000 description 1
- ZNVNRCCMWSAXAR-UHFFFAOYSA-N 4-(3-chlorophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=C(Cl)C=CC=2)=C1 ZNVNRCCMWSAXAR-UHFFFAOYSA-N 0.000 description 1
- OPTKBEWSJLCJML-UHFFFAOYSA-N 4-(3-chlorophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=C(Cl)C=CC=2)=C1 OPTKBEWSJLCJML-UHFFFAOYSA-N 0.000 description 1
- LDPHNLXGUPHKFA-UHFFFAOYSA-N 4-(3-fluorophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=C(F)C=CC=2)=C1 LDPHNLXGUPHKFA-UHFFFAOYSA-N 0.000 description 1
- QZBFCQXCBNUAED-UHFFFAOYSA-N 4-(3-fluorophenyl)-1-methylimidazole-2-carboxamide Chemical compound N1=C(C(N)=O)N(C)C=C1C1=CC=CC(F)=C1 QZBFCQXCBNUAED-UHFFFAOYSA-N 0.000 description 1
- GYUVTEHWNAJIOA-UHFFFAOYSA-N 4-(3-fluorophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=C(F)C=CC=2)=C1 GYUVTEHWNAJIOA-UHFFFAOYSA-N 0.000 description 1
- CJZYVDQTGZHESS-UHFFFAOYSA-N 4-(3-methoxy-4-methylsulfanylphenyl)-1,3-thiazole-2-carboxamide Chemical compound C1=C(SC)C(OC)=CC(C=2N=C(SC=2)C(N)=O)=C1 CJZYVDQTGZHESS-UHFFFAOYSA-N 0.000 description 1
- DNMLDTNDDOXZQM-UHFFFAOYSA-N 4-(3-methylphenyl)-1,3-thiazole-2-carboxamide Chemical compound CC1=CC=CC(C=2N=C(SC=2)C(N)=O)=C1 DNMLDTNDDOXZQM-UHFFFAOYSA-N 0.000 description 1
- DZZVRXDLYPRFSY-UHFFFAOYSA-N 4-(3-methylsulfanylphenyl)-1,3-thiazole-2-carboxamide Chemical compound CSC1=CC=CC(C=2N=C(SC=2)C(N)=O)=C1 DZZVRXDLYPRFSY-UHFFFAOYSA-N 0.000 description 1
- UEGWKFFKGKUZGY-UHFFFAOYSA-N 4-(3-nitrophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=C(C=CC=2)[N+]([O-])=O)=C1 UEGWKFFKGKUZGY-UHFFFAOYSA-N 0.000 description 1
- HYTNQBSWRRSXLX-UHFFFAOYSA-N 4-(4-bromophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=CC(Br)=CC=2)=C1 HYTNQBSWRRSXLX-UHFFFAOYSA-N 0.000 description 1
- QTVYFJQJUMOTEX-UHFFFAOYSA-N 4-(4-bromophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=CC(Br)=CC=2)=C1 QTVYFJQJUMOTEX-UHFFFAOYSA-N 0.000 description 1
- RFYFQEDSXDWTEA-UHFFFAOYSA-N 4-(4-cyclohexylphenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=CC(=CC=2)C2CCCCC2)=C1 RFYFQEDSXDWTEA-UHFFFAOYSA-N 0.000 description 1
- WPKHEYBIERVMJT-UHFFFAOYSA-N 4-(4-fluorophenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=CC(F)=CC=2)=C1 WPKHEYBIERVMJT-UHFFFAOYSA-N 0.000 description 1
- MSNPWENGSJZERD-UHFFFAOYSA-N 4-(4-fluorophenyl)-N'-hydroxy-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=CC(F)=CC=2)=C1 MSNPWENGSJZERD-UHFFFAOYSA-N 0.000 description 1
- RUQSNSDGMRDAAQ-UHFFFAOYSA-N 4-(4-hydroxy-3-methoxyphenyl)-1,3-thiazole-2-carboxamide Chemical compound C1=C(O)C(OC)=CC(C=2N=C(SC=2)C(N)=O)=C1 RUQSNSDGMRDAAQ-UHFFFAOYSA-N 0.000 description 1
- IAFUCDNAJSBJQH-UHFFFAOYSA-N 4-(4-hydroxyphenyl)-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=CC(O)=CC=2)=C1 IAFUCDNAJSBJQH-UHFFFAOYSA-N 0.000 description 1
- XIGBAPOVGIYCAR-UHFFFAOYSA-N 4-(4-methoxyphenyl)-1,3-thiazole-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=CSC(C(N)=O)=N1 XIGBAPOVGIYCAR-UHFFFAOYSA-N 0.000 description 1
- TWABEFGCOWFOKB-UHFFFAOYSA-N 4-(4-methylphenyl)-1,3-thiazole-2-carboxamide Chemical compound C1=CC(C)=CC=C1C1=CSC(C(N)=O)=N1 TWABEFGCOWFOKB-UHFFFAOYSA-N 0.000 description 1
- SYCBGPHQUQGYMH-UHFFFAOYSA-N 4-[3-(trifluoromethyl)phenyl]-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=C(C=CC=2)C(F)(F)F)=C1 SYCBGPHQUQGYMH-UHFFFAOYSA-N 0.000 description 1
- NJALRYLLCKMWGD-UHFFFAOYSA-N 4-[4-(trifluoromethyl)phenyl]-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2C=CC(=CC=2)C(F)(F)F)=C1 NJALRYLLCKMWGD-UHFFFAOYSA-N 0.000 description 1
- SOTTVQRFGPUVBM-UHFFFAOYSA-N 5-(3,4-dimethylphenyl)-1h-imidazole-2-carboxamide Chemical compound C1=C(C)C(C)=CC=C1C1=CNC(C(N)=O)=N1 SOTTVQRFGPUVBM-UHFFFAOYSA-N 0.000 description 1
- UESFBAADLWFWTF-UHFFFAOYSA-N 5-(3,4-dimethylphenyl)-N'-hydroxy-1H-imidazole-2-carboximidamide methanesulfonic acid Chemical compound CS(O)(=O)=O.Cc1ccc(cc1C)-c1c[nH]c(n1)C(=N)NO UESFBAADLWFWTF-UHFFFAOYSA-N 0.000 description 1
- KKSDIWNSDFNLNY-UHFFFAOYSA-N 5-(3-fluorophenyl)-1h-imidazole-2-carboxamide Chemical compound N1C(C(=O)N)=NC(C=2C=C(F)C=CC=2)=C1 KKSDIWNSDFNLNY-UHFFFAOYSA-N 0.000 description 1
- TYCDCKPCBFPZAH-UHFFFAOYSA-N 5-(3-fluorophenyl)-N'-hydroxy-1H-imidazole-2-carboximidamide methanesulfonic acid Chemical compound CS(O)(=O)=O.ONC(=N)c1nc(c[nH]1)-c1cccc(F)c1 TYCDCKPCBFPZAH-UHFFFAOYSA-N 0.000 description 1
- ZPWKJZIWAYCHGX-UHFFFAOYSA-N 5-(3-methylphenyl)-1h-imidazole-2-carboxamide Chemical compound CC1=CC=CC(C=2N=C(NC=2)C(N)=O)=C1 ZPWKJZIWAYCHGX-UHFFFAOYSA-N 0.000 description 1
- XNFLCRWXJBVDOW-UHFFFAOYSA-N 5-phenyl-1h-imidazole-2-carbonitrile Chemical compound N1C(C#N)=NC(C=2C=CC=CC=2)=C1 XNFLCRWXJBVDOW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- FMDVAOATQQTESZ-UHFFFAOYSA-N N'-hydroxy-4-(3-methylphenyl)-1,3-thiazole-2-carboximidamide Chemical compound CC1=CC=CC(C=2N=C(SC=2)C(=N)NO)=C1 FMDVAOATQQTESZ-UHFFFAOYSA-N 0.000 description 1
- WUDNGQRMLHBFNA-UHFFFAOYSA-N N'-hydroxy-4-(3-methylsulfanylphenyl)-1,3-thiazole-2-carboximidamide Chemical compound CSC1=CC=CC(C=2N=C(SC=2)C(=N)NO)=C1 WUDNGQRMLHBFNA-UHFFFAOYSA-N 0.000 description 1
- ABPIVAUEQHDUTM-UHFFFAOYSA-N N'-hydroxy-4-(3-nitrophenyl)-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=C(C=CC=2)[N+]([O-])=O)=C1 ABPIVAUEQHDUTM-UHFFFAOYSA-N 0.000 description 1
- DICFQHXBLCCMQN-UHFFFAOYSA-N N'-hydroxy-4-(4-hydroxyphenyl)-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=CC(O)=CC=2)=C1 DICFQHXBLCCMQN-UHFFFAOYSA-N 0.000 description 1
- PJWAFZLMURBUKJ-UHFFFAOYSA-N N'-hydroxy-4-(4-methoxyphenyl)-1,3-thiazole-2-carboximidamide Chemical compound C1=CC(OC)=CC=C1C1=CSC(C(=N)NO)=N1 PJWAFZLMURBUKJ-UHFFFAOYSA-N 0.000 description 1
- CTTYYERNQPAVFQ-UHFFFAOYSA-N N'-hydroxy-4-(4-methylphenyl)-1,3-thiazole-2-carboximidamide Chemical compound C1=CC(C)=CC=C1C1=CSC(C(=N)NO)=N1 CTTYYERNQPAVFQ-UHFFFAOYSA-N 0.000 description 1
- AISVIJYGHWLCGC-UHFFFAOYSA-N N'-hydroxy-4-phenyl-1,3-thiazole-2-carboximidamide Chemical compound S1C(C(=N)NO)=NC(C=2C=CC=CC=2)=C1 AISVIJYGHWLCGC-UHFFFAOYSA-N 0.000 description 1
- BHVDTSNNKSSTLR-UHFFFAOYSA-N N'-hydroxy-5-(3-methylphenyl)-1H-imidazole-2-carboximidamide methanesulfonic acid Chemical compound CS(O)(=O)=O.Cc1cccc(c1)-c1c[nH]c(n1)C(=N)NO BHVDTSNNKSSTLR-UHFFFAOYSA-N 0.000 description 1
- NFDJBJNLUITMNA-UHFFFAOYSA-N N'-hydroxy-5-phenyl-1H-imidazole-2-carboximidamide Chemical compound N1C(C(=N)NO)=NC(C=2C=CC=CC=2)=C1 NFDJBJNLUITMNA-UHFFFAOYSA-N 0.000 description 1
- CGNLFOIWPBSMGF-UHFFFAOYSA-N N'-hydroxy-5-phenyl-1H-imidazole-2-carboximidamide methanesulfonic acid Chemical compound CS(O)(=O)=O.ONC(=N)c1nc(c[nH]1)-c1ccccc1 CGNLFOIWPBSMGF-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 229940053202 antiepileptics carboxamide derivative Drugs 0.000 description 1
- 150000008365 aromatic ketones Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001964 calcium overload Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- WBKFWQBXFREOFH-UHFFFAOYSA-N dichloromethane;ethyl acetate Chemical compound ClCCl.CCOC(C)=O WBKFWQBXFREOFH-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- IHTSLFQBGDYDGV-UHFFFAOYSA-N ethyl 1-methyl-4-(3-methylphenyl)imidazole-2-carboxylate Chemical compound CN1C(C(=O)OCC)=NC(C=2C=C(C)C=CC=2)=C1 IHTSLFQBGDYDGV-UHFFFAOYSA-N 0.000 description 1
- YMBMCMOZIGSBOA-UHFFFAOYSA-N ethyl 2-amino-2-sulfanylideneacetate Chemical compound CCOC(=O)C(N)=S YMBMCMOZIGSBOA-UHFFFAOYSA-N 0.000 description 1
- RJQSYGIQWJSYBH-UHFFFAOYSA-N ethyl 4-[3-chloro-4-(dimethylcarbamoylsulfanyl)-5-methoxyphenyl]-1,3-thiazole-2-carboxylate Chemical compound S1C(C(=O)OCC)=NC(C=2C=C(OC)C(SC(=O)N(C)C)=C(Cl)C=2)=C1 RJQSYGIQWJSYBH-UHFFFAOYSA-N 0.000 description 1
- DNBIUWPIJOWUEU-UHFFFAOYSA-N ethyl 5-phenyl-1h-imidazole-2-carboxylate Chemical compound N1C(C(=O)OCC)=NC(C=2C=CC=CC=2)=C1 DNBIUWPIJOWUEU-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- KDGKTJGPFXIBEB-UHFFFAOYSA-N n-hydroxyformamide Chemical class ONC=O KDGKTJGPFXIBEB-UHFFFAOYSA-N 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- CVXGFPPAIUELDV-UHFFFAOYSA-N phenacylazanium;chloride Chemical compound [Cl-].[NH3+]CC(=O)C1=CC=CC=C1 CVXGFPPAIUELDV-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- CYFJIBWZIQDUSZ-UHFFFAOYSA-N thioglycine Chemical class NCC(S)=O CYFJIBWZIQDUSZ-UHFFFAOYSA-N 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polyurethanes Or Polyureas (AREA)
- Paints Or Removers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91302573 | 1991-03-25 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO921156D0 NO921156D0 (no) | 1992-03-24 |
| NO921156L NO921156L (no) | 1992-09-28 |
| NO301929B1 true NO301929B1 (no) | 1997-12-29 |
Family
ID=8208225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO921156A NO301929B1 (no) | 1991-03-25 | 1992-03-24 | 4-aryl-tiazol- eller -imidazol-derivater |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5254575A (de) |
| EP (1) | EP0506194B1 (de) |
| JP (1) | JPH0597816A (de) |
| KR (1) | KR920018037A (de) |
| AT (1) | ATE141597T1 (de) |
| AU (1) | AU648394B2 (de) |
| CA (1) | CA2063172A1 (de) |
| DE (1) | DE69212870T2 (de) |
| DK (1) | DK0506194T3 (de) |
| ES (1) | ES2093765T3 (de) |
| FI (1) | FI921262A (de) |
| GR (1) | GR3021260T3 (de) |
| IE (1) | IE73235B1 (de) |
| MX (1) | MX9203810A (de) |
| NO (1) | NO301929B1 (de) |
| NZ (1) | NZ242095A (de) |
| ZA (1) | ZA921781B (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922751A (en) * | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
| US5874437A (en) * | 1996-11-01 | 1999-02-23 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| CA2270118A1 (en) * | 1996-11-01 | 1998-05-14 | Nitromed Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| USRE37234E1 (en) | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
| US6331543B1 (en) | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| US5958926A (en) | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| AU6030098A (en) * | 1997-01-16 | 1998-08-07 | Neorx Corporation | Phalloidin derivatives and analogs to treat congestive heart failure |
| US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
| PT1212089E (pt) | 1999-08-21 | 2006-08-31 | Altana Pharma Ag | Combinacao sinergica de roflumilast e salmeterol |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| JP2006522151A (ja) | 2003-04-01 | 2006-09-28 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | 不妊症におけるホスホジエステラーゼ阻害剤 |
| CA2522476A1 (en) * | 2003-04-18 | 2004-11-04 | Merck & Co., Inc. | Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
| SA04250288B1 (ar) * | 2003-09-19 | 2008-07-19 | سولفاي فارماسوتيكالز بي . في | مشتقات ثيازول thiazole كمعدلات لمستقبل المكونات الكيميائية للقنب cannabinoid |
| AR056720A1 (es) * | 2005-10-26 | 2007-10-17 | Smithkline Beecham Corp | Compuesto de tiazol substtuido composicion farmaceuticamente que lo comprende y su uso para preparar un medicamento |
| CA3089569C (en) | 2007-06-04 | 2023-12-05 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| EP2321341B1 (de) | 2008-07-16 | 2017-02-22 | Synergy Pharmaceuticals Inc. | Zur behandlung von erkrankungen des magen-darm-trakts, entzündlichen erkrankungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CN108676076A (zh) | 2011-03-01 | 2018-10-19 | 辛纳吉制药公司 | 制备鸟苷酸环化酶c激动剂的方法 |
| JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
| EP2970384A1 (de) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonisten der guanylatcyclase und deren verwendungen |
| JP2016514670A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト |
| RS65632B1 (sr) | 2013-06-05 | 2024-07-31 | Bausch Health Ireland Ltd | Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe |
| WO2015021358A2 (en) | 2013-08-09 | 2015-02-12 | Dominique Charmot | Compounds and methods for inhibiting phosphate transport |
| JP2022533251A (ja) | 2019-05-21 | 2022-07-21 | アルデリックス， インコーポレイテッド | 患者において血清リン酸塩を低下させるための組み合わせ |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU168036B (de) * | 1973-11-09 | 1976-02-28 | ||
| FR2261756A1 (en) * | 1974-02-27 | 1975-09-19 | Roussel Uclaf | 2-Thiazole-N-(Piperazino or piperidino) alkyl carboxamides - as hypotensive and anti-hypertensive agents of low toxicity |
| EP0199968B1 (de) * | 1985-03-27 | 1990-02-28 | Zenyaku Kogyo Kabushiki Kaisha | Thiazolderivate |
| JPH02262562A (ja) * | 1988-10-20 | 1990-10-25 | Ishihara Sangyo Kaisha Ltd | イミダゾール系化合物 |
-
1992
- 1992-03-06 IE IE920734A patent/IE73235B1/en not_active IP Right Cessation
- 1992-03-10 ZA ZA921781A patent/ZA921781B/xx unknown
- 1992-03-13 AU AU12915/92A patent/AU648394B2/en not_active Ceased
- 1992-03-17 CA CA002063172A patent/CA2063172A1/en not_active Abandoned
- 1992-03-23 DE DE69212870T patent/DE69212870T2/de not_active Expired - Fee Related
- 1992-03-23 NZ NZ242095A patent/NZ242095A/en unknown
- 1992-03-23 EP EP92200825A patent/EP0506194B1/de not_active Expired - Lifetime
- 1992-03-23 DK DK92200825.5T patent/DK0506194T3/da active
- 1992-03-23 ES ES92200825T patent/ES2093765T3/es not_active Expired - Lifetime
- 1992-03-23 KR KR1019920004745A patent/KR920018037A/ko not_active Application Discontinuation
- 1992-03-23 AT AT92200825T patent/ATE141597T1/de not_active IP Right Cessation
- 1992-03-24 NO NO921156A patent/NO301929B1/no unknown
- 1992-03-24 FI FI921262A patent/FI921262A/fi not_active Application Discontinuation
- 1992-03-25 US US07/857,526 patent/US5254575A/en not_active Expired - Fee Related
- 1992-03-25 JP JP4067491A patent/JPH0597816A/ja active Pending
- 1992-06-29 MX MX9203810A patent/MX9203810A/es unknown
-
1993
- 1993-10-14 US US08/136,530 patent/US5462959A/en not_active Expired - Fee Related
-
1996
- 1996-10-04 GR GR960402611T patent/GR3021260T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI921262A0 (fi) | 1992-03-24 |
| AU1291592A (en) | 1992-10-01 |
| ES2093765T3 (es) | 1997-01-01 |
| CA2063172A1 (en) | 1992-09-26 |
| EP0506194A1 (de) | 1992-09-30 |
| FI921262A (fi) | 1992-09-26 |
| NO921156D0 (no) | 1992-03-24 |
| AU648394B2 (en) | 1994-04-21 |
| JPH0597816A (ja) | 1993-04-20 |
| IE920734A1 (en) | 1992-10-07 |
| DE69212870T2 (de) | 1997-01-16 |
| US5462959A (en) | 1995-10-31 |
| EP0506194B1 (de) | 1996-08-21 |
| NO921156L (no) | 1992-09-28 |
| NZ242095A (en) | 1994-04-27 |
| KR920018037A (ko) | 1992-10-21 |
| DE69212870D1 (de) | 1996-09-26 |
| IE73235B1 (en) | 1997-05-21 |
| GR3021260T3 (en) | 1997-01-31 |
| MX9203810A (es) | 1992-07-31 |
| ATE141597T1 (de) | 1996-09-15 |
| DK0506194T3 (da) | 1996-12-23 |
| US5254575A (en) | 1993-10-19 |
| ZA921781B (en) | 1992-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO301929B1 (no) | 4-aryl-tiazol- eller -imidazol-derivater | |
| JP2923742B2 (ja) | ４−アミノキナゾリン誘導体、その製造方法およびそれを含有する医薬品 | |
| US4500525A (en) | Pharmacologically active pyrazolo/4,3-c/pyridines | |
| NO180750B (no) | Pyrazolopyrimidinoner som antianginale midler | |
| MXPA06013593A (es) | Nuevos derivados de piridazin-3(2h)-ona. | |
| NZ501275A (en) | 2-substituted 4,5-diaryl imidazoles | |
| JP2002542245A (ja) | 置換イミダゾール、それらの製造および使用 | |
| NO164476B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,3,5-tetrahydroimidazo-(2,1-b)-kinazoliner. | |
| US4612318A (en) | CNS-depressant and analgesic tricyclo-[pyrazolo-[3,4-6]-pyridine] derivatives and pharmaceutical compositions thereof | |
| HU187478B (en) | Process for preparing new imidazolyl-phenyl-amidines and pharmaceutical compositions containing thereof | |
| EP1412353B1 (de) | Imidazopyridinone als p38 map kinase inhibitoren | |
| Juby et al. | Preparation and antiinflammatory properties of some 1-substituted 3-(5-tetrazolylmethyl) indoles and homologs | |
| CA1271751A (en) | Dihydroimidazo[1,2-a]pyrimidine derivatives | |
| US4684658A (en) | Anti-thrombotic ortho-condensed pyrrole derivatives, compositions, and method of use therefor | |
| NO151893B (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 3h-nafto(1,2-d)imidazolderivater | |
| SK3702001A3 (en) | 2-phenylpyran-4-one derivatives | |
| NO791648L (no) | Fremgangsmaate ved fremstilling av nye kinazolinderivater | |
| CZ281213B6 (cs) | Způsob výroby oxoftalazinyloctových kyselin a jejich analogů | |
| ES2259704T3 (es) | Compuestos benzoilicos. | |
| SK42299A3 (en) | N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics | |
| NO830758L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fenyl-4,5,6,7-tetrahydro tieno (2,3-c) pyridin-derivater | |
| US5198441A (en) | Derivatives of 1,2-dihydro 2-oxo quinoxalines, their preparation and their use in therapy | |
| CS244653B2 (en) | Production method of new pyridazinel-hydrazone derivatives | |
| NO874780L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater. | |
| NO131345B (de) |